U.S. Guidelines panel recommendation for long-acting injectable antiretroviral regimen in adults and adolescents with HIV
28 Feb, 2021 | 20:34h | UTCWhat’s New in the Guidelines? Panel’s Recommendation for Long-Acting Injectable Cabotegravir and Rilpivirine in Persons with HIV